<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="10.17917/H65D-SJ70" scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><h2>NCL Method GTA-4: Hep G2 Hepatocyte Lipid Peroxidation Assay</h2><hr><p>This protocol describes the analysis of human hepatocarcinoma cells (Hep G2) for lipid peroxidation products such as malondialdehyde (MDA), following treatment with nanoparticle formulations, as part of the in vitro NCL preclinical characterization cascade.</p><h3>File name: protocols/20240410_18-24-58-711_NCL_Method_GTA-4.pdf</h3><h3>DOI: <a href = http://dx.doi.org/10.17917/H65D-SJ70>http://dx.doi.org/10.17917/H65D-SJ70</a></h3<br><h3>Resource Type:  Protocol</h3><h3>Data Access: <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a></h3></body></html>